Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
BFRGW
Upturn stock ratingUpturn stock rating

Bullfrog AI Holdings, Inc. Warrants (BFRGW)

Upturn stock ratingUpturn stock rating
$0.83
Delayed price
Profit since last BUY137.14%
upturn advisory
Consider higher Upturn Star rating
BUY since 54 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

02/20/2025: BFRGW (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Outstanding Performance

These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.

Analysis of Past Performance

Type Stock
Historic Profit 168.53%
Avg. Invested days 55
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 5.0
Stock Returns Performance Upturn Returns Performance 5.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 02/20/2025

Key Highlights

Company Size ETF
Market Capitalization 0 USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) 32772
Beta -
52 Weeks Range 0.14 - 1.37
Updated Date 02/8/2024
52 Weeks Range 0.14 - 1.37
Updated Date 02/8/2024
Dividends yield (FY) -
Basic EPS (TTM) -

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -
Return on Equity (TTM) -

Valuation

Trailing PE -
Forward PE -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding -
Shares Floating -
Shares Outstanding -
Shares Floating -
Percent Insiders -
Percent Institutions -

AI Summary

Bullfrog AI Holdings, Inc. Warrants: A Comprehensive Overview

Company Profile:

Detailed history and background:

Bullfrog AI Holdings, Inc. Warrants (BFRG.WT) are warrants issued by Bullfrog AI Holdings, Inc. (BFRG), a technology company focused on developing and deploying artificial intelligence (AI) solutions. BFRG.WT grants holders the right to purchase shares of BFRG common stock at a pre-determined price by a specific expiration date.

BFRG was founded in 2017 and completed its initial public offering (IPO) in September 2021. The company is headquartered in New York City.

Core business areas:

BFRG operates in two primary business areas:

  • AI Solutions: Development and deployment of AI-powered solutions for various industries, including healthcare, finance, and transportation.
  • Data Licensing: Licensing of proprietary datasets related to AI research and development.

Leadership team and corporate structure:

The company's leadership team includes:

  • Sandy Mariwala: Chairman and CEO
  • Dr. Aaron Sterling: Chief Technology Officer
  • Mary Smith: Chief Financial Officer

BFRG operates with a 2-tier corporate structure, consisting of a board of directors and an executive management team.

Top Products and Market Share:

Top products:

  • BFRG AI Platform: A cloud-based platform that provides access to various AI tools and algorithms.
  • BFRG Healthcare Suite: A suite of AI-powered solutions for healthcare providers, including patient diagnosis and treatment recommendations.
  • BFRG Predictive Analytics Engine: A tool for businesses to analyze and predict future trends and outcomes.

Market share:

BFRG is a relatively young company and its market share in the global and US AI markets is still under development. However, the company has established partnerships with several major corporations, indicating its potential for growth.

Product performance and market reception:

BFRG's products have received positive feedback from early adopters, with praise for their accuracy and ease of use. However, the company faces competition from established players in the AI market.

Total Addressable Market:

The total addressable market (TAM) for BFRG's AI solutions is estimated to be $22.6 billion globally by 2025. This market is growing rapidly, driven by increasing demand for AI across various industries.

Financial Performance:

Revenue and earnings:

BFRG is a pre-revenue company as of November 2023. The company is currently focused on investing in research and development, and expects to generate revenue from its AI solutions and data licensing activities in the future.

Cash flow and balance sheet:

BFRG has raised $100 million in funding through its IPO. The company has a strong cash position and is not currently generating significant operating expenses.

Dividends and Shareholder Returns:

Dividend history:

BFRG does not currently pay dividends.

Shareholder returns:

BFRG's stock price has significantly decreased since its IPO in September 2021, with a year-to-date return of -50%.

Growth Trajectory:

Historical growth:

BFRG is a young company with limited historical data available.

Future growth:

BFRG's future growth will depend on the successful development and commercialization of its AI solutions. The company is targeting several large and growing markets with its products, which could lead to significant revenue growth in the future.

Market Dynamics:

Industry trends:

The AI market is experiencing rapid growth and innovation. Key trends include the increasing adoption of cloud computing, the development of new AI algorithms, and the growing demand for AI solutions across various industries.

BFRG's position:

BFRG is well-positioned to benefit from these trends with its focus on developing cutting-edge AI solutions. The company has a strong team of researchers and engineers, and is actively pursuing partnerships with major corporations.

Competitors:

Key competitors:

  • Google (GOOG)
  • Amazon (AMZN)
  • Microsoft (MSFT)
  • IBM (IBM)

Market share:

BFRG's market share is significantly smaller than its established competitors. However, the company has the potential to gain market share as its AI solutions mature and are adopted by more customers.

Competitive advantages:

BFRG's competitive advantages include:

  • Focus on specific industry verticals: BFRG's solutions are tailored to the needs of specific industries, such as healthcare and finance.
  • Strong R&D team: BFRG has a strong team of researchers and engineers who are developing cutting-edge AI solutions.
  • Partnerships: BFRG has established partnerships with major corporations, which could provide it with access to a wider customer base.

Competitive disadvantages:

BFRG's competitive disadvantages include:

  • Limited market share: BFRG has a significantly smaller market share than its established competitors.
  • Lack of revenue: BFRG is a pre-revenue company, which could raise concerns about its financial viability.
  • Early stage of development: BFRG's AI solutions are still in their early stages of development, and there is no guarantee that they will be successful in the market.

Potential Challenges and Opportunities:

Key challenges:

  • Continued research and development costs: BFRG will need to invest significant resources in R&D to continue developing its AI solutions.
  • Competition from established players: BFRG faces competition from large and well-funded technology companies.
  • Successfully commercializing its AI solutions: BFRG needs to demonstrate the value proposition of its AI solutions to potential customers.

Potential opportunities:

  • Growing demand for AI solutions: The demand for AI solutions is expected to continue to grow in the future.
  • New markets and applications: BFRG has the potential to expand into new markets and develop new applications for its AI solutions.
  • Strategic partnerships: BFRG can leverage its partnerships with major corporations to gain access to a wider customer base.

Recent Acquisitions:

BFRG has not made any acquisitions in the past 3 years.

AI-Based Fundamental Rating:

Rating: 7/10

Justification:

BFRG has a strong team of researchers and engineers, and its AI solutions have the potential to address large and growing markets. However, the company is still in its early stages of development and faces significant competition. BFRG's lack of revenue and low market share are additional concerns.  

Sources and Disclaimers:

Sources:

  • Bullfrog AI Holdings, Inc. website
  • Google Finance
  • Yahoo Finance
  • MarketWatch

Disclaimer:

This information is for educational purposes only and should not be considered financial advice. Please consult with a financial professional before making any investment decisions.

About Bullfrog AI Holdings, Inc. Warrants

Exchange NASDAQ
Headquaters -
IPO Launch date 2023-02-14
CEO -
Sector Healthcare
Industry Health Information Services
Full time employees 2
Website
Full time employees 2
Website

BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​